T2 Biosystems, Inc. (TTOO)
NASDAQ: TTOO · Real-Time Price · USD
0.968
-0.082 (-7.81%)
At close: Oct 29, 2024, 4:00 PM
0.980
+0.012 (1.24%)
After-hours: Oct 29, 2024, 7:45 PM EDT

T2 Biosystems Revenue

T2 Biosystems had revenue of $1.95M in the quarter ending June 30, 2024, a decrease of -0.61%. This brings the company's revenue in the last twelve months to $7.16M, down -45.74% year-over-year. In the year 2023, T2 Biosystems had annual revenue of $7.19M, down -67.75%.

Revenue (ttm)
$7.16M
Revenue Growth
-45.74%
P/S Ratio
0.97
Revenue / Employee
$63,398
Employees
113
Market Cap
16.92M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20237.19M-15.11M-67.75%
Dec 31, 202222.31M-5.75M-20.50%
Dec 31, 202128.06M9.93M54.76%
Dec 31, 202018.13M9.80M117.52%
Dec 31, 20198.34M-2.16M-20.62%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
bioAffinity Technologies 7.32M
Sol-Gel Technologies 6.56M
QT Imaging Holdings 3.11M
TherapeuticsMD 996.00K
Bullfrog AI 65.00K
Revenue Rankings